Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 4, 2011, Pages 600-605

  Bastek, Jamie A ^a   Brown, Amy G ^a   Anton, Lauren ^a   Srinivas, Sindhu K ^a   D'Addio, Antonietta ^a   Elovitz, Michal A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarker; high sensitivity C reactive protein; placental growth factor; preterm birth

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PLACENTAL GROWTH FACTOR;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; NONPARAMETRIC TEST; PATHOGENESIS; PLACENTA DISORDER; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFLAMMATION; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY PROTEINS; PREMATURE BIRTH; PROGNOSIS; RISK FACTORS;

EID: 79952430846     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.511340     Document Type: Article

References (27)

1. Assessment of risk factors for preterm birth. ACOG Practice Bulletin No. 31. American College of Obstetricians and Gynecologists. Obstet Gynecol 2001;98:709-716.
2. Gonçalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002;8:3-13. (Pubitemid 34754487)
3. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342: 1500-1507. (Pubitemid 30318275)
4. Elovitz MA. Anti-inflammatory interventions in pregnancy: now and the future. Semin Fetal Neonatal Med 2006;11:327-332. (Pubitemid 44038702)
5. Park JS, Park CW, Lockwood CJ, Norwitz ER. Role of cytokines in preterm labor and birth. Minerva Ginecol 2005;57: 349-366. (Pubitemid 41503742)
6. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF III, Petraglia F. Inflammation and pregnancy. Reprod Sci 2009; 16:206-215.
7. Cunningham GF, Leveno K J, Bloom SL, Hauth JC, Gilstrap LC III, Wenstrom KD. Williams obstetrics, 22nd ed. New York: McGraw-Hill Companies; 2005.
8. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 1982;389:39.
9. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins and serum amyloid A protein). Adv Immunol 1983;34:141-212. (Pubitemid 14089437)
10. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336: 973-979. (Pubitemid 27152782)
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97:425-428. (Pubitemid 28090212)
12. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Dö ring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease. Augsburg Cohort Study, 1984 to 1992). Circulation 1999;99:237-242.
13. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733. (Pubitemid 28391836)
14. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17: 1121-1127.
15. Kuller LH, Tracy RP, Shaten J, Meilahn EN; for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547. (Pubitemid 26304398)
16. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-466. (Pubitemid 27077826)
17. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45:2136-2141.
18. Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, Connor JM, Dobbie R. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 2007;109:1316-1324. (Pubitemid 46869870)
19. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683. (Pubitemid 38364626)
20. Ghosh G, Breborowicz A, Brazert M, Maczkiewicz M, Kobelski M, Dubiel M, Gudmundsson S. Evaluation of third trimester uterine artery flow velocity indices in relationship to perinatal complications. J Matern Fetal Neonatal Med 2006;19:551-555. (Pubitemid 44373607)
21. Misra VK, Hobel CJ, Sing CF. Placental blood flow and the risk of preterm delivery. Placenta 2009;30:619-624.
22. Ledue TB, Weiner DL, Sipe J, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A, and mannose binding protein in human serum. Ann Clin Biochem 1998;35:745-753. (Pubitemid 28523808)
23. Bastek JA, Sammel MD, Srinivas SK, Elovitz MA. Is routine infectious and toxicologic screening in preterm labor effective in predicting preterm birth? Am J Obstet Gynecol 2008;198: e38-e42.
24. Muñ oz A, Gange S. Methodological issues for biomarkers and intermediate outcomes in cohort studies. Epidemiol Rev 1998;20:29-42. (Pubitemid 28449751)
25. Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001;47:403-411. (Pubitemid 32222452)
26. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005;162:1108-1113. (Pubitemid 41746623)
27. Skrablin S, Lovric H, Banovic V, Kralik S, Dijakovic A, Kalafatic D. Maternal plasma interleukin-6, interleukin-1beta and C-reactive protein as indicators of tocolysis failure and neonatal outcome after preterm delivery. J Matern Fetal Neonatal Med 2007;20:335-341. (Pubitemid 47221605)